is glp3 retatrutide Reta (GLP-3) research product Retatrutide (GLP-3 R) | BleauGenics

Participants receiving tirzepatide reached a 20.2% mean weight reduction at 72 weeks, whereas the semaglutide group lost 13.7%

Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure

Keep a simple journal of any perceived benefits, drawbacks, or side effects over the course of weeks to months, not just days

And if something looks like it's growing, we just stop the medication and take care of it

Other Intervals (Less Common for these Peptides): Depending on the peptide, other intervals like every other day, or even bi-weekly (every two weeks), might be used